{
    "Trade/Device Name(s)": [
        "ARCHITECT\u00ae BNP",
        "ARCHITECT BNP Reagent Kit",
        "ARCHITECT BNP Calibrator Kit",
        "ARCHITECT BNP Control Kit"
    ],
    "Submitter Information": "Fujirebio Diagnostics, Inc.",
    "510(k) Number": "K060964",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033606"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBC",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "April 5, 2006",
    "Summary Letter Received Date": "April 7, 2006",
    "Submission Date": "April 4, 2006",
    "Regulation Number(s)": [
        "21CFR862.1175"
    ],
    "Regulation Name(s)": [
        "Cholesterol (total) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "B-type natriuretic peptide (BNP)"
    ],
    "Specimen Type(s)": [
        "EDTA plasma"
    ],
    "Specimen Container(s)": [
        "Plastic collection tubes"
    ],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT BNP assay for quantitative determination of BNP in EDTA plasma using CMIA technology on the ARCHITECT i System.",
    "Indications for Use Summary": "A chemiluminescent microparticle immunoassay for quantitative determination of human B-type natriuretic peptide (BNP) in EDTA plasma as an aid in the diagnosis and assessment of severity of heart failure.",
    "fda_folder": "Clinical Chemistry"
}